Early Postoperative Complications after Pelvic Exenteration

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Radiation therapy is an integral part of the treatment of most malignant neoplasms of the pelvic organs, which in 25–30% of cases can cause the development of late radiation complications; in addition, 2–8% of patients have severe complications with an outcome in fistulas of various localization. Also, tumors of this localization are prone to local-regional recurrence, which can be combined with late radiation injuries. One of the most radical, and, often, the only method of treating this extremely severe and prognostically unfavorable pathology is to perform evisceration of the pelvic organs; however, its implementation against the background of radiation damage to normal tissues, leading to a significant decrease in the reparative potential, inevitably leads to a high risk of postoperative complications.

Methods. A retrospective analysis of early postoperative complications on the Clavien–Dindo scale was carried out in 136 patients after pelvic evisceration performed at the A.F. Tsyba MRSC in 2019–2021. All patients in the perioperative period underwent complex conservative therapy, including nutritional support.

Results. Pelvic evisceration was performed due to the progression of the underlying disease in 57% of cases, in 29% — due to the development of severe late radiation injuries with an outcome in the fistula, in 14% — due to a combination of local recurrence of the underlying disease with radiation complications). Complications of grade I on the Clavien–Dindo scale were noted in 50%; II — in 20.5%; III — in 3.6%; grade IV — in 3%. There were no cases of postoperative mortality.

Conclusions. Conducting active preoperative preparation of patients aimed at correcting anemia, dysproteinemia, pain syndrome, etc.; as well as modifying surgical techniques and improving the management tactics of postoperative patients can minimize the risk of postoperative complications in patients after pelvic evisceration.

Full Text

Restricted Access

About the authors

Valery A. Korotkov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: korotkov910@mail.ru
ORCID iD: 0000-0001-7919-9750

MD, PhD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Leonid O. Petrov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: leonid_petrov@mail.ru
ORCID iD: 0000-0001-6272-9647
SPIN-code: 4559-3613
Scopus Author ID: 665865

MD, PhD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Aleksandr L. Potapov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: ALP8@yandex.ru
ORCID iD: 0000-0003-3752-3107

MD, PhD, Professor

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Veronika N. Shitareva

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: veronikashitareva@gmail.com
ORCID iD: 0000-0002-0031-0354

MD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Vitaly Yu. Skoropad

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: skoropad@mrrc.obninsk.ru
ORCID iD: 0000-0002-2136-1994
SPIN-code: 2283-1111
ResearcherId: E-2200-2018

MD, PhD, Professor

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Pavel V. Sokolov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: sokolov-p-v@yandex.ru

MD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Maksim R. Kasymov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: makskas89@yandex.ru
ORCID iD: 0000-0001-8202-8055

MD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Victor V. Pasov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: pasov@mrrc.obninsk.ru
ORCID iD: 0000-0003-0387-1648
SPIN-code: 8778-2401
Scopus Author ID: 767404

MD, PhD, Professor

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Lilia V. Tivkova

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: ova.lika@yandex.ru

MD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Anastasia S. Yamshikova

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

Email: kolmykova1996@gmail.com

MD

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region

Sergey A. Ivanov

A. Tsyb Medical Radiological Research Centre — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; RUDN University

Email: mrrc@mrrc.obninsk.ru
ORCID iD: 0000-0001-7689-6032
SPIN-code: 4264-5167

MD, PhD, Professor of the RAS

Russian Federation, 10 Zhukova str., 249031, Obninsk, Kaluga Region; Moscow

Andrey D. Kaprin

National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; RUDN University; P. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Moscow

Email: mrrc@mrrc.obninsk.ru
ORCID iD: 0000-0001-8784-8415
SPIN-code: 1759-8101

MD, PhD, Professor, Academician of the RAS

Russian Federation, Obninsk, Kaluga Region; Moscow; Moscow

References

  1. Состояние онкологической помощи населению России в 2021 г. / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. — М.: МНИОИ им. П.А. Герцена, 2022. — 239 с. [Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 g. / pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj. Moscow: MNIOI im. P.A. Gercena; 2022. 239 s. (In Russ.)]
  2. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: https://doi.org/10.3322/caac.21660
  3. Рак шейки матки: клинические рекомендации. — М.: Мин-здрав России, 2020. [Rak shejki matki: klinicheskie rekomendacii. Moscow: Minzdrav Rossii; 2020. (In Russ.)] Available from: https://cr.minzdrav.gov.ru/recomend/537_1
  4. Рак тела матки и саркомы матки: клинические рекомендации. — М.: Минздрав России, 2021. [Rak tela matki i sarkomy matki: klinicheskie rekomendacii. Moscow: Minzdrav Rossii; 2021. (In Russ.)] Available from: https://cr.minzdrav.gov.ru/recomend/460_3
  5. Рак прямой кишки: клинические рекомендации. — М.: Мин-здрав России, 2022. [Rak pryamoj kishki: klinicheskie rekomendacii. Moscow: Minzdrav Rossii; 2022. (In Russ.)] Available from: https://cr.minzdrav.gov.ru/recomend/554_3
  6. Рак предстательной железы: клинические рекомендации. — М.: Минздрав России, 2021. [Rak predstatel’noj zhelezy: klinicheskie rekomendacii. Moscow: Minzdrav Rossii; 2021. (In Russ.)] Available from: https://cr.minzdrav.gov.ru/recomend/12_3
  7. Рак мочевого пузыря: клинические рекомендации. — М.: Минздрав России, 2020. [Rak mochevogo puzyrya: klinicheskie rekomendacii. Moscow: Minzdrav Rossii; 2020. (In Russ.)] Available from: https://cr.minzdrav.gov.ru/schema/11_2
  8. Сычева И.В. Лечение лучевых повреждений органов малого таза после лучевой терапии рака предстательной железы // Сибирский онкологический журнал. — 2018. — Т. 17. — № 3. — С. 64–71. [Sycheva IV. Treatment of radiation-induced pelvic damage after radiation therapy for prostate cancer. Siberian Journal of Oncology. 2018;17(3):64–71. (In Russ.)] doi: https://doi.org/10.21294/1814-4861-2018-17-3-64-71
  9. Datta NR, Stutz E, Liu M, et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol. 2017;145(2):374–385. doi: https://doi.org/10.1016/j.ygyno.2017.01.033
  10. Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–2965. doi: https://doi.org/10.1200/JCO.2007.10.8324
  11. Пасов В.В., Коротков В.А., Касымов М.Р., и др. Принципы лечения поздних лучевых повреждений прямой кишки у онкологических больных // Андрология и генитальная хирургия. — 2021. — Т. 22. — № 1. — С. 21–27. [Pasov VV, Korotkov VA, Kasymov MR, et al. Principles of treatment of late rectal radiation damage in cancer patients. Andrology and Genital Surgery. 2021;22(1):21–27. (In Russ.)] doi: https://doi.org/10.17650/1726-9784-2021-22-1-21-27
  12. Mann WJ. Exenteration for gynecologic cancer. Available from: https://www.uptodate.com/contents/exenteration-for-gynecologic-cancer (аccessed: 26.03.2021).
  13. PelvEx Collaborative. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy. Ann Surg. 2019;270(5):899–905. doi: https://doi.org/10.1097/SLA.0000000000003533
  14. PelvEx Collaborative. Palliative pelvic exenteration: A systematic review of patient-centered outcomes. Eur J Surg Oncol. 2019;45(10):1787–1795. doi: https://doi.org/10.1016/j.ejso.2019.06.011
  15. The Jamovi Project (2022). Jamovi (Version 2.3) [Computer Software]. Available from: https://www.jamovi.org
  16. Pleth Nielsen CK, Sørensen MM, Christensen HK, et al. Complications and survival after total pelvic exenteration. Eur J Surg Oncol. 2022;48(6):1362–1367. doi: https://doi.org/10.1016/j.ejso.2021.12.472
  17. Костюк И.П., Шестаев А.Ю., Крестьянинов С.С., и др. Осложнения хирургического лечения больных злокачественными новообразованиями органов малого таза, распространяющимися на мочевой пузырь // Вестник Военно-медицинской академии. — 2012. — Т. 39. — № 3. — С. 15–21. [Kostyuk IP, Shestaev AYu, Krestyaninov SS, et al. Complications of surgical treatment of patients with malignant pelvic tumors applicable to the bladder. Vestnik Voenno-Medicinskoj Akademii. 2012;39(3):15–21. (In Russ.)]
  18. Калинин Е.В., Россомахина О.М. Мультивисцеральные резекции и тотальные эвисцерации органов малого таза при местно-распространенных формах рака примой кишки // Поволжский онкологический вестник. — 2017. — Т. 29. — № 2. — С. 62–66. [Kalinin EV, Rossomakhina OM. Multivisceral resection and total pelvic evisceration for locally advanced rectal cancer. Oncology Bulletin of the Volga Region. 2017;29(2):62–66. (In Russ.)]
  19. Scott MJ, Baldini G, Fearon KCH, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations. Acta Anaesthesiol Scand. 2015;59(10):1212–1231. doi: https://doi.org/10.1111/aas.12601
  20. Lau CS, Chamberlain RS. Enhanced recovery after surgery programs improve patient outcomes and recovery: a meta-analysis. World J Surg. 2017;41(4):899–913. doi: https://doi.org/10.1007/s00268-016-3807-4

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies